Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia.

@article{Upthegrove2019CytokinesOS,
  title={Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia.},
  author={Rachel Upthegrove and Golam M. Khandaker},
  journal={Current topics in behavioral neurosciences},
  year={2019}
}
In this article, we review current evidence linking immune dysfunction in schizophrenia and related psychotic disorders focusing particularly on circulating cytokines, oxidative stress and cellular markers of inflammation in various stages on illness from drug-naïve first episode psychosis to chronic schizophrenia. Acute psychotic episode is associated with low-grade systemic inflammation in some patients, as reflected by increased concentrations of cytokines and other inflammatory markers in… 
Interrelationships Between Oxidative Stress, Cytokines, and Psychotic Symptoms and Executive Functions in Patients With Chronic Schizophrenia
TLDR
The findings suggest that the interrelationships between oxidative stress markers and cytokines occur in schizophrenia patients, which may be the basis of their pathological mechanisms underlying clinical symptoms and cognitive dysfunction.
Increased Markers of Oxidative Stress and Positive Correlation Low-Grade Inflammation with Positive Symptoms in the First Episode of Schizophrenia in Drug-Naïve Patients
TLDR
The elevated level of superoxide dismutase in patients with the first episode of schizophrenia can be explained by compensatory mechanisms to counteract oxidative stress.
Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia
TLDR
The results demonstrate the sex difference in the relationship between TNF-α, MDA, and their interaction with psychopathological symptoms of patients with schizophrenia.
Cytokine Alterations in Schizophrenia: An Updated Review
TLDR
There is a substantial need for studies investigating the levels of cytokines before disease development and delineating the therapeutic implications of the disrupted cytokine levels in schizophrenia, and the available evidence shows a potential causative role for cytokines in schizophrenia development.
The Role of Peripheral Inflammation in Clinical Outcome and Brain Imaging Abnormalities in Psychosis: A Systematic Review
TLDR
Systematic searches of the literature using the databases PsychInfo, OVID Medline, and Embase were conducted to collate studies investigating the association of inflammatory biomarkers with clinical outcome in patients with psychotic disorders and studies examining the relationships betweeninflammatory biomarkers and neuroimaging data.
Oxidative Stress in the Early Stage of Psychosis.
TLDR
A significantly reduced antioxidant defense has been described in the early onset first episode of psychosis, including reduced levels of glutathione, and the importance that must be given to anti-oxidant defense systems is indicated.
Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection
TLDR
The results suggest long-standing effects of prenatal infections on schizophrenia-like behavioral deficits are mediated by immune-inflammatory and apoptotic pathways, increased oxidative stress toxicity, and lowered antioxidant and neuroprotective defenses.
Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives
TLDR
It is suggested that not only antioxidants but also redox-regulated transcription factor-targeting drugs (including Nrf2 and FoxO activators or NF-κB inhibitors) have great promise in schizophrenia, but it is necessary to develop the stratification criteria of schizophrenia patients based on oxidative stress-related markers for the administration of red ox-correcting treatment.
Regulation of Reactive Oxygen Species-Mediated Damage in the Pathogenesis of Schizophrenia
TLDR
By improving the understanding of the effects of various nutrients on schizophrenia, it may become possible to develop nutritional strategies and supplements to treat the disorder, alleviate its symptoms, and facilitate long-term recovery.
...
...

References

SHOWING 1-10 OF 96 REFERENCES
C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
TLDR
Whether there is a causal relationship between higher CRP levels and the development of SZ and aggravation of psychotic symptoms, or whether they are solely a marker of systemic low-grade inflammation in SZ, remains to be clarified.
Is there a role for immune-to-brain communication in schizophrenia?
TLDR
Whether persistent low-grade activation of the innate immune response, as a result of impaired foetal or childhood development, could be a common mechanism underlying the high comorbidity between certain neuropsychiatric and physical illnesses, such as schizophrenia, depression, heart disease and type-two diabetes, is considered.
Inflammatory Biomarkers and Risk of Schizophrenia
TLDR
A protective effect of CRP and a risk-increasing effect of sIL-6R (potentially mediated at least in part by CRP) on schizophrenia risk is suggested, and it is possible that such effects are a result of increased susceptibility to early life infection.
Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study.
TLDR
Higher levels of the systemic inflammatory marker IL-6 in childhood are associated with an increased risk of developing depression and psychosis in young adulthood, and inflammatory pathways may provide important new intervention and prevention targets for these disorders.
A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression
TLDR
Overall, there were similarities in the pattern of cytokine alterations in schizophrenia, bipolar disorder and MDD during acute and chronic phases of illness, raising the possibility of common underlying pathways for immune dysfunction.
...
...